Clinical Trials Directory

Trials / Completed

CompletedNCT01010451

Antimicrobial Pulpotomy of Primary Molars

Survival of Primary Molars Treated With Antimicrobial Pulpotomy or Calcium Hydroxide Pulpectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
Universidade Federal de Goias · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

There is a lack of evidence of the long-term successful outcomes of antimicrobial endodontic treatment for primary teeth. This study intended to evaluate (by survival analysis) the effectiveness of an antimicrobial pulpotomy (chloramphenicol, tetracycline, zinc oxide/eugenol) in primary molars compared to calcium hydroxide pulpectomy, testing the hypothesis that antimicrobial pulpotomy could be an alternative pulp therapy for primary teeth with pulp inflammation or necrosis.

Conditions

Interventions

TypeNameDescription
PROCEDUREAntimicrobial pulpotomyPulpotomy of inflamed or necrotic pulp using an antimicrobial paste (chloramphenicol, tetracycline, zinc oxide/eugenol)as medication.
PROCEDURECalcium hydroxide pulpectomyPulpectomy of inflamed or necrotic pulp using a calcium hydroxide paste as medication

Timeline

Start date
2000-08-01
Completion
2006-08-01
First posted
2009-11-10
Last updated
2009-11-10

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01010451. Inclusion in this directory is not an endorsement.